Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab

Ann Rheum Dis. 2007 Oct;66(10):1402-3. doi: 10.1136/ard.2007.071878.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / immunology*
  • Female
  • Humans
  • Influenza Vaccines / immunology*
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Rituximab
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Influenza Vaccines
  • Tumor Necrosis Factor-alpha
  • Rituximab